More broadly, combined ChaC-MS data predicted that, via AD-phenotypic interactions with key translation regulators such as HNRNPA2B1 and other regulators of ribosomal biogenesis, G9a has a noncanonical (nonepigenetic) function in translational and post-translational regulation of AD pathogenesis. The gene discussed is EHMT2; the disease is Alzheimer disease.